" class="no-js "lang="en-US"> Tom Kupper - Medtech Alert
Saturday, August 02, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Tom Kupper

Tom Kupper

About Tom Kupper

Co-founder of Bloom Diagnostics, who has developed a digital test system that combines biotechnology, real-time data processing and medical research all in one product.  Their aim is to provide people with information about their health in an understandable way, without all the noise.

Related Story

Equipment

 Smart CRP Test Gets Green Light for Professional Use as Swiss Medtech Company Expands Across Europe | Pharmtech Focus

Smart CRP Test Gets Green Light for Professional Use as Swiss Medtech Company Expands Across Europe

July 8 2022

Swiss medtech company Bloom Diagnostics has today announced the launch of the Bloom Inflammation Test, […]